
DILI-on-chip (Drug Induced Liver Injury) addresses the development of a microfluidic device to assess in vitro adverse drug reactions, on a human-like liver lobule. From a unique donor, hiPSCs (human induced pluripotent stem cells) will be differentiated to obtain the different types of cells, hepatocytes as well as non-parenchymal cells, that compose the liver lobule. Hepatocytes forming the hepatic cord, bordered by endothelial cells forming the sinusoid, and cholangiocytes forming the bile ducts will be organized in 3D on the chip, in order to get a functional unit mimicking the Hering channel.
Next to the DILI-onChip Agenda…
- Next Technical meeting, march, 2025Our next technical meeting will be held in Paris in march, 19th 2025, 14h-17h, at LVTS, INSERM 1148, Hôpital […]
DILI publications
Last Events
- Last Technical meeting, november 7th 2024 (visio)
- PhD defense of Alan Rajendran, ENS Paris-Saclay
- Technical meeting, may 24th 2024, St Grégoire
- PhD defense of Chao Le Bao, LVTS
- phd defense of Manon Boul, ENS Paris-Saclay
Reports of the technical meetings


